The Clinic
The Centre of Molecular Immunology (CIM) — where groundbreaking science meets compassionate care
World-Class Biotechnology Research Facility
NeuralCIM is exclusively available through Cuba's Centre of Molecular Immunology (CIM), a world-renowned biotechnology research and treatment facility that has been at the forefront of medical innovation for decades.
Located in Cuba, CIM represents the convergence of cutting-edge science and compassionate care. The clinic is the only facility in the world where patients can access this groundbreaking NeuralCIM treatment.
Havana, Cuba
The only facility offering NeuralCIM treatment worldwide
Why This Clinic is the Only Provider
Despite the promising results of NeuralCIM, access to this treatment faces significant challenges that make CIM the sole provider worldwide.
Pioneering Research
CIM was founded by Dr. Teresita Rodríguez Obaya specifically to develop innovative treatments for neurodegenerative diseases. The facility houses the original research team that created NeuralCIM and continues to refine the treatment.
Regulatory Approval
NeuralCIM has received accelerated approval from the Cuban Regulatory Authority (CECMED) specifically for use at CIM. This specialized approval framework makes CIM the exclusive provider.
Specialized Medical Team
The clinic employs a dedicated team of neurologists and neuropsychiatrists specifically trained in NeuralCIM administration and monitoring. This specialized expertise cannot be replicated elsewhere.
Integrated Care Model
CIM provides comprehensive care including evaluation, treatment administration, monitoring, and follow-up in one facility. This integrated approach ensures optimal patient outcomes.
The Impact of the U.S. Blockade
Because of the decades-long U.S. blockade, producing NeuralCIM has been extraordinarily difficult. The dedicated scientists at CIM have persevered despite tremendous obstacles.
Prevents Critical Supplies
The blockade prevents supplies that Cuban biotechnology scientists need for their research from reaching Cuba.
10% Rule Barrier
Blocks any items made with more than 10% U.S. material, effectively cutting Cuba off from most nearby resources.
Research Collaboration Limits
Prevents people in the U.S. from directly supporting Cuban medical science and research collaboration.
"Despite these challenges, the dedicated scientists at CIM have persevered, making NeuralCIM available to patients from around the world who seek hope for Alzheimer's and Parkinson's treatment."
Patient Safety Protocols
Based on clinical study documentation, NeuralCIM has demonstrated an excellent safety profile with comprehensive monitoring protocols.
No Serious Adverse Events
No serious adverse events related to NeuralCIM were reported in clinical studies involving 170+ participants.
Standardized Assessments
Patients are monitored throughout the treatment period with standardized cognitive assessments and regular evaluations.
Excellent Safety Profile
Treatment demonstrated a very good safety profile with high patient tolerance throughout the clinical trials.
"Teresita's Dream: Cuba's Battle Against Alzheimer's"
The clinic's research has been documented by Belly of the Beast, chronicling the third phase of efficacy studies and the remarkable story behind this breakthrough treatment.
This powerful documentary follows Dr. Teresita Rodríguez Obaya and her team as they navigate the challenges of developing NeuralCIM while facing the constraints of the U.S. blockade. It captures the human determination behind the science.
Teresita's Dream
Belly of the Beast Documentary
La Pradera Clinic
NeuralCIM treatment is provided at La Pradera in Cuba — the exclusive facility where patients can access this groundbreaking treatment.
A dedicated team of neurologists and neuropsychiatrists works with each patient during the evaluation process, ensuring comprehensive assessment and personalized care.
Ready to Learn More?
Take the first step toward accessing NeuralCIM treatment. Our team is here to guide you through every step of the process.